Laurence Katznelson1. 1. Departments of Medicine and Neurosurgery, Stanford University School of Medicine, 875 Blake Wilbur Dr MC 5826, Stanford, CA, 94305, USA, lkatznelson@stanford.edu.
Abstract
PURPOSE: Review the indications, outcomes, and consequences of bilateral adrenalectomy (BLA) in patients with Cushing's disease. METHODS: A literature review was performed. RESULTS: The primary therapy for Cushing's disease is surgery, with medical therapy and radiation therapy relegated to an adjuvant role. BLA is indicated in cases of persistent disease following pituitary surgery or in situations where rapid normalization of hypercortisolism is required. When performed via the laparoscopic approach, BLA is associated with a significantly reduced morbidity compared to the traditional, open approach. Following BLA, patients are at risk for adrenal crisis and the concern of Nelson's syndrome. However, BLA leads to a rapid resolution of the signs and symptoms of CS and leads to an improved long-term quality of life. CONCLUSION: BLA should be considered in the treatment algorithm for patients with persistent CD after failed pituitary surgery, especially in patients who have severe consequences of hypercortisolism or desire pregnancy.
PURPOSE: Review the indications, outcomes, and consequences of bilateral adrenalectomy (BLA) in patients with Cushing's disease. METHODS: A literature review was performed. RESULTS: The primary therapy for Cushing's disease is surgery, with medical therapy and radiation therapy relegated to an adjuvant role. BLA is indicated in cases of persistent disease following pituitary surgery or in situations where rapid normalization of hypercortisolism is required. When performed via the laparoscopic approach, BLA is associated with a significantly reduced morbidity compared to the traditional, open approach. Following BLA, patients are at risk for adrenal crisis and the concern of Nelson's syndrome. However, BLA leads to a rapid resolution of the signs and symptoms of CS and leads to an improved long-term quality of life. CONCLUSION: BLA should be considered in the treatment algorithm for patients with persistent CD after failed pituitary surgery, especially in patients who have severe consequences of hypercortisolism or desire pregnancy.
Authors: Sarah K Thompson; Amanda V Hayman; William H Ludlam; Clifford W Deveney; D Lynn Loriaux; Brett C Sheppard Journal: Ann Surg Date: 2007-05 Impact factor: 12.969
Authors: Philip W Smith; Kristin C Turza; Cullen O Carter; Mary Lee Vance; Edward R Laws; John B Hanks Journal: J Am Coll Surg Date: 2009-04-24 Impact factor: 6.113
Authors: Andrea Oßwald; Eva Plomer; Christina Dimopoulou; Monika Milian; Rainer Blaser; Katrin Ritzel; Anne Mickisch; Ferengis Knerr; Milan Stanojevic; Klaus Hallfeldt; Jochen Schopohl; Klaus A Kuhn; Günter Stalla; Felix Beuschlein; Martin Reincke Journal: Eur J Endocrinol Date: 2014-08 Impact factor: 6.664
Authors: Maria Fleseriu; Richard Auchus; Irina Bancos; Anat Ben-Shlomo; Jerome Bertherat; Nienke R Biermasz; Cesar L Boguszewski; Marcello D Bronstein; Michael Buchfelder; John D Carmichael; Felipe F Casanueva; Frederic Castinetti; Philippe Chanson; James Findling; Mônica Gadelha; Eliza B Geer; Andrea Giustina; Ashley Grossman; Mark Gurnell; Ken Ho; Adriana G Ioachimescu; Ursula B Kaiser; Niki Karavitaki; Laurence Katznelson; Daniel F Kelly; André Lacroix; Ann McCormack; Shlomo Melmed; Mark Molitch; Pietro Mortini; John Newell-Price; Lynnette Nieman; Alberto M Pereira; Stephan Petersenn; Rosario Pivonello; Hershel Raff; Martin Reincke; Roberto Salvatori; Carla Scaroni; Ilan Shimon; Constantine A Stratakis; Brooke Swearingen; Antoine Tabarin; Yutaka Takahashi; Marily Theodoropoulou; Stylianos Tsagarakis; Elena Valassi; Elena V Varlamov; Greisa Vila; John Wass; Susan M Webb; Maria C Zatelli; Beverly M K Biller Journal: Lancet Diabetes Endocrinol Date: 2021-10-20 Impact factor: 32.069
Authors: Mawson Wang; Benjamin Jonker; Louise Killen; Yvonne Bogum; Ann McCormack; Ramy H Bishay Journal: Endocrinol Diabetes Metab Case Rep Date: 2020-07-05
Authors: Luis Marín-Martínez; Antonio J Ríos-Vergara; Georgios Kyriakos; Maria C Álvarez-Martín; Enrique Hernández-Alonso Journal: Cureus Date: 2022-04-19
Authors: Eleni Papakokkinou; Marta Piasecka; Hanne Krage Carlsen; Dimitrios Chantzichristos; Daniel S Olsson; Per Dahlqvist; Maria Petersson; Katarina Berinder; Sophie Bensing; Charlotte Höybye; Britt Edén Engström; Pia Burman; Cecilia Follin; David Petranek; Eva Marie Erfurth; Jeanette Wahlberg; Bertil Ekman; Anna-Karin Åkerman; Erik Schwarcz; Gudmundur Johannsson; Henrik Falhammar; Oskar Ragnarsson Journal: Pituitary Date: 2021-05-25 Impact factor: 4.107
Authors: Kim M J A Claessen; Cornelie D Andela; Nienke R Biermasz; Alberto M Pereira Journal: Front Endocrinol (Lausanne) Date: 2021-07-20 Impact factor: 5.555